PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
38.07%
Some net income increase while CNQ is negative at -180.15%. John Neff would see a short-term edge over the struggling competitor.
-5.43%
Both reduce yoy D&A, with CNQ at -48.51%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
17.62%
Deferred tax of 17.62% while CNQ is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
275.00%
SBC growth well above CNQ's 108.93%. Michael Burry would flag major dilution risk vs. competitor’s approach.
1.72%
Slight usage while CNQ is negative at -106.69%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-53.82%
AR is negative yoy while CNQ is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.72%
Some yoy usage while CNQ is negative at -106.69%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-253.19%
Both negative yoy, with CNQ at -101.93%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-64.96%
Both yoy CFO lines are negative, with CNQ at -60.88%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-28.21%
Negative yoy CapEx while CNQ is 9.45%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-99.34%
Negative yoy acquisition while CNQ stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
290.96%
Purchases growth of 290.96% while CNQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-95.71%
We reduce yoy sales while CNQ is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-27.76%
Both yoy lines negative, with CNQ at -165.02%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-217.12%
Both yoy lines negative, with CNQ at -41.39%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
78.13%
We repay more while CNQ is negative at -660.27%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.